Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Desiree Van Oorschot
Cost-Effectiveness of an Adjuvanted Recombinant Zoster Vaccine in Older Adults in the United States Who Have Been Previously Vaccinated With Zoster Vaccine Live
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
Zoster Vaccine Live
Pharmacotherapy
Pharmacology
Cost-Effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine
JAMA Internal Medicine
Internal Medicine
Herpes Zoster Vaccine in Older Adults With Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Better Effectiveness of Herpes Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus With Ocular Involvement
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation
JAMA - Journal of the American Medical Association
Medicine
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Disseminated Varicella Zoster Virus Infection After Vaccination With a Live Attenuated Vaccine
CMAJ
Medicine
Exam 3: Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Pin53 - Is the Recombinant Zoster Vaccine Also Cost-Effective for the German Population ≥50 Years of Age?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
